Pharmacologic Anticoagulation Reversal in the Emergency DepartmentLemon, Stephen J. Jr. PharmD; Crannage, Andrew J. PharmD, BCPS Section Editor(s): Weant, Kyle PharmD, BCPS; Column Editor Advanced Emergency Nursing Journal: July/September 2011 - Volume 33 - Issue 3 - p 212–223 doi: 10.1097/TME.0b013e31822638ae APPLIED PHARMACOLOGY Buy CE Abstract Author InformationAuthors Article MetricsMetrics Anticoagulation therapies are 1 of the most commonly encountered therapeutic areas by health care professionals each day. One of the most important adverse effects of anticoagulation therapy is life-threatening hemorrhage, and it may result in visits to the emergency department. Some of the common reversal agents include Vitamin K, protamine sulfate, desmopressin, recombinant Factor VIIa, and prothrombin complex concentrates. Each of these agents has the potential to reverse specific anticoagulation therapies, but each agent has a unique administration procedure and monitoring parameters. However, these agents are not without risk of adverse effects. Knowledge of unique aspects of each reversal agent and the anticoagulation therapy must be considered when selecting or recommending pharmacologic anticoagulation reversal therapy. The intent of this review is to discuss the relevant management issues associated with anticoagulant reversal in the emergency department. Department of Pharmacy, Cleveland Clinic, Ohio (Dr Lemon); and Department of Pharmacy Practice, St. Louis College of Pharmacy, Missouri (Dr Crannage). Corresponding Author: Stephen J. Lemon Jr., PharmD, 9500 Euclid Avenue, JJN1-2, Cleveland, OH 44195 (firstname.lastname@example.org). Disclosure: The authors report no conflicts of interest. © 2011 Lippincott Williams & Wilkins, Inc.